Correlation Between Diamyd Medical and NetSol Technologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Diamyd Medical and NetSol Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Diamyd Medical and NetSol Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Diamyd Medical AB and NetSol Technologies, you can compare the effects of market volatilities on Diamyd Medical and NetSol Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Diamyd Medical with a short position of NetSol Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Diamyd Medical and NetSol Technologies.

Diversification Opportunities for Diamyd Medical and NetSol Technologies

-0.56
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Diamyd and NetSol is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Diamyd Medical AB and NetSol Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NetSol Technologies and Diamyd Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Diamyd Medical AB are associated (or correlated) with NetSol Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NetSol Technologies has no effect on the direction of Diamyd Medical i.e., Diamyd Medical and NetSol Technologies go up and down completely randomly.

Pair Corralation between Diamyd Medical and NetSol Technologies

Assuming the 90 days horizon Diamyd Medical AB is expected to generate 1.1 times more return on investment than NetSol Technologies. However, Diamyd Medical is 1.1 times more volatile than NetSol Technologies. It trades about -0.11 of its potential returns per unit of risk. NetSol Technologies is currently generating about -0.22 per unit of risk. If you would invest  109.00  in Diamyd Medical AB on August 29, 2024 and sell it today you would lose (10.00) from holding Diamyd Medical AB or give up 9.17% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Diamyd Medical AB  vs.  NetSol Technologies

 Performance 
       Timeline  
Diamyd Medical AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Diamyd Medical AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
NetSol Technologies 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in NetSol Technologies are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, NetSol Technologies may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Diamyd Medical and NetSol Technologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Diamyd Medical and NetSol Technologies

The main advantage of trading using opposite Diamyd Medical and NetSol Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Diamyd Medical position performs unexpectedly, NetSol Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NetSol Technologies will offset losses from the drop in NetSol Technologies' long position.
The idea behind Diamyd Medical AB and NetSol Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Commodity Directory
Find actively traded commodities issued by global exchanges
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators